All participants must register to attend Evidentiary Considerations for Integration of Biomarkers in Drug Development, a one-day symposium scheduled for August 21, 2015.
Thank you for your interest in Evidentiary Considerations for Integration of Biomarkers in Drug Development, a one-day symposium jointly sponsored by the University of Maryland Center Excellence in Regulatory Science and Innovation (M-CERSI), Critical Path Institute (C-Path), and the Food and Drug Administration. This conference will provide a forum for researchers from academia, industry, payers, and other stakeholders to come together to discuss an overview of biomarkers in drug development, biomarker qualification, and evidentiary considerations for biomarker utilization in drug development.
How to Register:
Registration for this event is now closed.